Infectious Disease Treatment Market: Global Industry Size, Growth, Outlook and Forecast 2016-2022 – Brisk Insights
According to a recently published report, the Infectious Disease Treatment Market is expected to grow by 8.2% CAGR during 2015-2022. The segmentation of global infectious disease treatment market is based onend user,application, product, technique and geography. The report on global infectious disease treatment market forecast 2015-2022 (by end user, application, product, technique and geography) provides detailed overview and predictive analysis of the market.
Detailed study on this Report: http://www.briskinsights.com/report/infectious-disease-treatment-market
The escalating incidences of infectious diseases and the enhanced management &control of infectious diseases isdrivingthe growth in the global infectious disease treatment market. HIV is the major health issue across the globe, according to WHO, in 2014 around 34 million people claimed it and around 1.6 million people died due to HIV globally. In spite of driving factors there are some factors which are restricting the growth of global infectious disease treatment market such ashigh healthcare cost, restricts usage of novel techniques and deferment authorizations of new diagnostic tests etc. The growing demand in emerging economies, increasing research and development initiatives and rising demand for personalized medicinearethekey opportunities available in the global market. The rising prevalence of infectious diseases in Asia Pacific region is tha major factor that is uplifting the growth and creating the opportunities in the global market for the forecasted period. However, the increasing investment opportunities from emerging countries are also creating developing platform in the global market.
For Same Category Reports Visit Here: http://www.briskinsights.com/category/pharmaceutical-industry
Scope of the report
- GLOBAL INFECTIOUS DISEASE TREATMENT MARKET BY APPLICATION 2012-2022 ($ MILLION)
1.2. CHLAMYDIA TRACHOMATIS AND NEISSERIA GONORRHOEAE (CT/NG)
1.3. HEPATITIS B
1.4. HEPATITIS C
1.5. HUMAN PAPILLOMAVIRUS (HPV) INFECTION
1.6. METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS (MRSA) HOSPITAL ACQUIRED INFECTION
1.7. TUBERCULOSIS (TB)
- GLOBAL INFECTIOUS DISEASE TREATMENT MARKET BY END USER APPLICATION 2012-2022 ($ MILLION)
2.2. HOSPITALS LABORATORIES
2.3. PHYSICIAN OFFICE LABS
2.4. REFERENCE LABS
- GLOBAL INFECTIOUS DISEASE TREATMENT MARKET BY PRODUCT 2012-2022 ($ MILLION)
3.2. INSTRUMENTS & ANALYZERS
3.3. SERVICES & SOFTWARE’S
- GLOBAL INFECTIOUS DISEASE TREATMENT MARKET BY TECHNIQUE 2012-2022 ($ MILLION)
4.1. MOLECULAR DIAGNOSTICS
4.1.1. DNA SEQUENCING & NGS
4.2. TRADITIONAL DIAGNOSTIC TECHNIQUES
4.2.1. BIOCHEMICAL CHARACTERIZATION
- GLOBAL INFECTIOUS DISEASE TREATMENT MARKET REGIONAL OUTLOOK 2012-2022($MILLION)
5.1. NORTH AMERICA
5.3. ASIA PACIFIC
5.4. MIDDLE EAST & AFRICA
5.5. LATIN AMERICA
- COMPANY PROFILE
6.1. ABBOTT LABORATORIES
6.2. ALERE, INC.
6.3. BECTON, DICKINSON & CO.
6.4. BIO-RAD LABORATORIES
6.6. DANAHER CORPORATION
6.8. IPCA LABORATORIES
6.9. JOHNSON AND JOHNSON
6.10. NOVARTIS INTERNATIONAL
6.12. ROCHE DIAGNOSTICS
6.13. SIEMENS HEALTHCARE
6.14. THERMO FISHER SCIENTIFIC, INC.
6.15. VERTEX PHARMACEUTICALS
Latest More Reports:
About Us :
Brisk Insights is a global market research firm. Our insightful analysis is focused on developed and emerging markets. We identify trends and forecast markets with a view to aid businesses identify market opportunities optimize strategies.
Working in a highly dynamic and multi-dimensional business makes decision making complex. Effective business decisions are a result of the synthesis of market information. Our Research and data analysis is an efficient and cost-effective way of providing robust market analysis and can yield highly valuable intelligence relating to consumers, competitors and markets.
Contact Us :
109 Vernon House
Phone : +448081890034 (UK)
Email : firstname.lastname@example.org
Website : http://www.briskinsights.com/